These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

202 related items for PubMed ID: 10623516

  • 1. Inhibition of HIV-1 entry before gp41 folds into its fusion-active conformation.
    Kliger Y, Shai Y.
    J Mol Biol; 2000 Jan 14; 295(2):163-8. PubMed ID: 10623516
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Mode of action of an antiviral peptide from HIV-1. Inhibition at a post-lipid mixing stage.
    Kliger Y, Gallo SA, Peisajovich SG, Munoz-Barroso I, Avkin S, Blumenthal R, Shai Y.
    J Biol Chem; 2001 Jan 12; 276(2):1391-7. PubMed ID: 11027678
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. HIV-1 membrane fusion mechanism: structural studies of the interactions between biologically-active peptides from gp41.
    Lawless MK, Barney S, Guthrie KI, Bucy TB, Petteway SR, Merutka G.
    Biochemistry; 1996 Oct 22; 35(42):13697-708. PubMed ID: 8885850
    [Abstract] [Full Text] [Related]

  • 10. A salt bridge between an N-terminal coiled coil of gp41 and an antiviral agent targeted to the gp41 core is important for anti-HIV-1 activity.
    Jiang S, Debnath AK.
    Biochem Biophys Res Commun; 2000 Apr 02; 270(1):153-7. PubMed ID: 10733920
    [Abstract] [Full Text] [Related]

  • 11. ADS-J1 inhibits HIV-1 infection and membrane fusion by targeting the highly conserved pocket in the gp41 NHR-trimer.
    Yu F, Lu L, Liu Q, Yu X, Wang L, He E, Zou P, Du L, Sanders RW, Liu S, Jiang S.
    Biochim Biophys Acta; 2014 May 02; 1838(5):1296-305. PubMed ID: 24388952
    [Abstract] [Full Text] [Related]

  • 12. Chemoenzymatic synthesis of HIV-1 gp41 glycopeptides: effects of glycosylation on the anti-HIV activity and alpha-helix bundle-forming ability of peptide C34.
    Wang LX, Song H, Liu S, Lu H, Jiang S, Ni J, Li H.
    Chembiochem; 2005 Jun 02; 6(6):1068-74. PubMed ID: 15883971
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Crystal structure of the simian immunodeficiency virus (SIV) gp41 core: conserved helical interactions underlie the broad inhibitory activity of gp41 peptides.
    Malashkevich VN, Chan DC, Chutkowski CT, Kim PS.
    Proc Natl Acad Sci U S A; 1998 Aug 04; 95(16):9134-9. PubMed ID: 9689046
    [Abstract] [Full Text] [Related]

  • 16. Functional and structural characterization of HIV-1 gp41 ectodomain regions in phospholipid membranes suggests that the fusion-active conformation is extended.
    Korazim O, Sackett K, Shai Y.
    J Mol Biol; 2006 Dec 15; 364(5):1103-17. PubMed ID: 17045292
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Design of a novel peptide inhibitor of HIV fusion that disrupts the internal trimeric coiled-coil of gp41.
    Bewley CA, Louis JM, Ghirlando R, Clore GM.
    J Biol Chem; 2002 Apr 19; 277(16):14238-45. PubMed ID: 11859089
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.